Nkarta director granted options on 37,000 shares
Nkarta, Inc. director Patterson Leone D received a grant of stock options covering 37,000 shares of common stock at an exercise price of $2.46 per share.
Rhea-AI Filing Summary
Nkarta, Inc. director Patterson Leone D received a grant of stock options covering 37,000 shares of common stock at an exercise price of $2.46 per share. The options vest 100% on the earlier of June 10, 2027 or the day before the first annual stockholder meeting after the grant date.
These options expire on June 9, 2036 and will fully vest if there is a qualifying change in control, or if the director’s service ends due to death or disability. This filing reflects a compensation-related award rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 37,000 shares
Grant/Award
1 txn
Insider
PATTERSON LEONE D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 37,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 37,000 contracts (Direct)
Footnotes (1)
- F1. All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).
Key Figures
Option grant size: 37,000 shares
Exercise price: $2.46 per share
Post-grant derivative holdings: 37,000 options
+2 more
5 metrics
Option grant size
37,000 shares
Stock Option (right to buy) underlying common stock shares
Exercise price
$2.46 per share
Conversion or exercise price of the stock option grant
Post-grant derivative holdings
37,000 options
Total derivative shares following the transaction
Option expiration date
June 9, 2036
Expiration date of the granted stock options
Cliff vesting date
June 10, 2027
Scheduled 100% vesting date absent earlier events
Key Terms
Stock Option (right to buy), exercise price, expiration date, change in control, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 2.4600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
change in control financial
"will become fully vested should a "change in control" of the Issuer occur"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
disability financial
"separation from service with the Issuer due to the Reporting Person's death or "disability""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nkarta (NKTX) report in this Form 4?
Nkarta reported a director receiving a stock option grant for 37,000 shares of common stock. The award is a compensation-related grant, not an open-market purchase or sale, and gives the right to buy shares at a fixed exercise price.
What are the key terms of the Nkarta (NKTX) director stock option grant?
The director received options on 37,000 shares at an exercise price of $2.46 per share. All options vest 100% based on future service or events and expire on June 9, 2036 if not exercised under the plan’s terms.
When do the newly granted Nkarta (NKTX) options vest for the director?
All shares under the option vest 100% on the earlier of June 10, 2027 or the day immediately before the first annual stockholder meeting following the grant date, assuming continued service and no earlier acceleration events occur.
Can the Nkarta (NKTX) director’s options vest earlier than 2027?
Yes. The grant becomes fully vested if a qualifying change in control occurs, or if the director’s service ends due to death or disability, as described in the applicable award agreement’s definitions and conditions.
Does this Nkarta (NKTX) Form 4 show any stock being bought or sold on the market?
No. The Form 4 reflects a grant of stock options with an exercise price of $2.46, not an open-market purchase or sale of common shares. It records a compensation award rather than trading activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
